Health Care & Life Sciences » Pharmaceuticals | Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
95,936
131,285
139,047
154,345
140,200
112,263
Total Accounts Receivable
23,304
55,843
80,698
84,976
79,067
91,936
Inventories
32,590
58,509
68,648
77,351
68,807
78,860
Other Current Assets
35,035
45,583
11,020
12,864
28,285
27,633
Total Current Assets
186,865
291,219
299,413
329,537
316,359
310,692
Net Property, Plant & Equipment
46,078
88,840
92,047
104,572
105,935
109,382
Total Investments and Advances
8,051
6,430
20,234
14,894
31,572
40,306
Long-Term Note Receivable
320
8,374
1,073
698
22,425
170
Intangible Assets
33,191
62,141
92,611
104,165
107,243
123,095
Other Assets
7,337
14,773
18,434
35,308
37,557
37,744
Total Assets
293,841
494,236
559,416
619,118
643,028
646,938
ST Debt & Current Portion LT Debt
25,122
76,277
53,865
83,957
79,797
Accounts Payable
13,311
31,650
35,829
43,954
47,662
Income Tax Payable
2,615
5,892
2,472
1,471
1,328
Other Current Liabilities
18,848
49,711
39,274
49,488
69,856
Total Current Liabilities
59,896
163,530
131,440
178,870
198,643
Long-Term Debt
487
13,684
31,103
14,361
17,721
Provision for Risks & Charges
23,980
25,070
18,959
12,111
4,045
Deferred Taxes
9,110
17,516
30,462
21,780
19,748
Other Liabilities
2,128
2,117
1,930
1,169
583
Total Liabilities
89,380
209,343
188,572
214,675
223,181
Common Equity (Total)
185,250
256,232
329,825
366,397
381,006
Total Shareholders' Equity
185,250
256,232
329,825
366,397
381,006
Total Equity
204,461
284,744
370,677
404,305
419,847
Liabilities & Shareholders' Equity
293,841
494,236
559,416
619,118
643,028
Accumulated Minority Interest
19,212
28,512
40,853
37,909
38,842
Non-Equity Reserves
-
149
167
138
-

About Sun Pharmaceutical Industries

View Profile
Address
CTS No. 201 B/1, Sun House
Mumbai Maharashtra 400063
India
Employees -
Website http://www.sunpharma.com
Updated 07/08/2019
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It operates through the following geographical segments: India, United States of America, Emerging Markets, and Rest of the World. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids.